CARMA study is entering the final stage of enrollment
We are happy to announce that the enrollment into the CARMA study is moving fast with 31 patients enrolled out of a target of 40 patients. Thanks all sites for their committment!
CARMA is a a multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age. It is part of the EPIICAL project, which is financed by ViiV Healthcare U.K. (ViiV).